Carter on CMS action to reduce prescription drug costs
WASHINGTON, D.C. – The Centers for Medicare and Medicaid Services (CMS) announced a rule change Thursday that would rein in pharmacy direct and indirect remuneration fees (DIR). Rep. Earl L. “Buddy” Carter (R-GA), a pharmacist by training, has long advocated for an end to predatory DIR fees and is encouraged by this action from CMS. “DIR fees are 107,400% higher today than they were…